CompanyGraph
At a glance
- Depends onUpstream position: supplies 5 industries, depends on 1
- ScaleMarket cap is $1.77B, above the global median of $1.18B
- FinancialsAltman Z-Score 2.56: grey zone
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
0.43%Below 5Y avg (1.30%)
Annual Rate
CNY 0.07Paid annual
Payout Ratio
32.3%Sustainable
Last Ex-Dividend
Sep 10, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
11.83BCNY1.77B · vs all stocks (USD)
Trailing P/E
45.44xvs Medical Instruments & Supplies peers
Revenue (TTM)
5.34BCNY796.68M · vs all stocks (USD)
Profit Margin
4.91%vs Medical Instruments & Supplies peers
Beta
0.3590xvs all stocks
52-Week Change
9.50%vs all stocks
Market Capitalization
11.83BCNY1.77B · vs all stocks (USD)
Enterprise Value
7.76BCNY1.16B · vs all stocks (USD)
Trailing P/E
45.44xvs Medical Instruments & Supplies peers
Forward P/E
21.46xvs Medical Instruments & Supplies peers
Price to Sales (TTM)
2.22xvs Medical Instruments & Supplies peers
Price to Book (MRQ)
1.47xvs Medical Instruments & Supplies peers
Enterprise to Revenue
1.45xvs Medical Instruments & Supplies peers
Enterprise to EBITDA
16.86xvs Medical Instruments & Supplies peers
Gross Margin
33.40%vs Medical Instruments & Supplies peers
Profit Margin
4.91%vs Medical Instruments & Supplies peers
Operating Margin
7.40%vs Medical Instruments & Supplies peers
Return on Assets (TTM)
1.47%vs Medical Instruments & Supplies peers
Return on Equity (TTM)
3.58%vs Medical Instruments & Supplies peers
Revenue (TTM)
5.34BCNY796.68M · vs all stocks (USD)
Revenue per Share (TTM)
6.92CNYUpdated Sep 20, 2026Quarterly Revenue Growth
10.50%vs Medical Instruments & Supplies peers
Gross Profit (TTM)
1.51BCNY225.85M · vs all stocks (USD)
EBITDA (TTM)
538.25MCNY80.32M · vs all stocks (USD)
Net Income (TTM)
262.14MCNY39.12M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
210.90%vs Medical Instruments & Supplies peers
Operating Cash Flow (TTM)
545.56MCNY81.41M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
356.75MCNY53.23M · vs all stocks (USD)
Trailing Annual Dividend Rate
0.0660CNYUpdated Sep 20, 2026Trailing Annual Dividend Yield
0.43%vs all stocks
5-Year Average Dividend Yield
1.30%vs all stocks
Payout Ratio
32.25%vs Medical Instruments & Supplies peers
Minority Interest (Equity)
238.45MCNYFY2025 · Dec 31, 2025Revenue
5.23BCNYFY2025 · Dec 31, 2025Cost of Goods Sold
3.70BCNYFY2025 · Dec 31, 2025Gross Profit
1.54BCNYFY2025 · Dec 31, 2025Operating Income
325.21MCNY48.53M · vs all stocks (USD)
Pre-tax Income
264.17MCNYFY2025 · Dec 31, 2025Income Tax Expense
52.28MCNYFY2025 · Dec 31, 2025Net Income
211.89MCNYFY2025 · Dec 31, 2025EBIT
265.83MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
538.25MCNYFY2025 · Dec 31, 2025Research & Development
337.66MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
361.04MCNYFY2025 · Dec 31, 2025Other Operating Expenses
45.65MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
37.84MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
1.66MCNYFY2025 · Dec 31, 2025EPS (Basic)
0.2600CNYFY2025 · Dec 31, 2025EPS (Diluted)
0.2600CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
770.68MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
770.68MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
211.89MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
-11.51MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
220.08MCNYFY2025 · Dec 31, 2025Free Cash Flow
-49.06MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
3.05BCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
211.89MCNYFY2025 · Dec 31, 2025Other Non-cash Items
26.86MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
58.51MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-77.18MCNYFY2025 · Dec 31, 2025Capital Expenditures
-269.14MCNYFY2025 · Dec 31, 2025Net Acquisitions
42.02MCNYFY2025 · Dec 31, 2025Purchase of Investments
-2.89BCNYFY2025 · Dec 31, 2025Sale of Investments
2.98BCNYFY2025 · Dec 31, 2025Other Investing Activity
1.31MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-133.53MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
76.70MCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-3.00MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-82.02MCNYFY2025 · Dec 31, 2025Other Financing Charges
-12.81MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-21.13MCNYFY2025 · Dec 31, 2025Shares Outstanding
765.83MSharesUpdated Sep 20, 2026Float Shares
364.48MSharesUpdated Sep 20, 2026% Held by Insiders
53.46%vs all stocks
% Held by Institutions
11.76%vs all stocks
Total Cash (MRQ)
4.36BCNY651.30M · vs all stocks (USD)
Total Cash per Share (MRQ)
5.74CNYUpdated Sep 20, 2026Total Debt (MRQ)
111.22MCNY16.60M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.0135xvs Medical Instruments & Supplies peers
Current Ratio (MRQ)
1.95xvs Medical Instruments & Supplies peers
Book Value per Share (MRQ)
10.48CNYUpdated Sep 20, 2026Total Assets
13.51BCNY2.02B · vs all stocks (USD)
Total Current Assets
10.17BCNYFY2025 · Dec 31, 2025Total Liabilities
5.34BCNYFY2025 · Dec 31, 2025Total Non-current Assets
3.34BCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
210.37MCNYFY2025 · Dec 31, 2025Total Current Liabilities
5.13BCNYFY2025 · Dec 31, 2025Cash
3.05BCNYFY2025 · Dec 31, 2025Cash Equivalents
69.10MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
3.12BCNYFY2025 · Dec 31, 2025Other Short-term Investments
714.71MCNYFY2025 · Dec 31, 2025Accounts Receivable
1.59BCNYFY2025 · Dec 31, 2025Inventory
3.20BCNYFY2025 · Dec 31, 2025Accounts Payable
1.08BCNYFY2025 · Dec 31, 2025Short-term Debt
15.98MCNYFY2025 · Dec 31, 2025Other Current Liabilities
180.68MCNYFY2025 · Dec 31, 2025Long-term Debt
72.19MCNYFY2025 · Dec 31, 2025Other Non-current Liabilities
6.39MCNYFY2025 · Dec 31, 2025Common Stock (Book)
765.83MCNYFY2025 · Dec 31, 2025Retained Earnings
3.17BCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
8.17BCNY1.22B · vs all stocks (USD)
Treasury Stock
63.94MCNYFY2025 · Dec 31, 202552-Week Low
10.42CNYUpdated Sep 20, 202652-Week High
20.37CNYUpdated Sep 20, 202652-Week Change
9.50%vs all stocks
Beta
0.3590xvs all stocks
50-Day MA
13.34CNYUpdated Sep 20, 2026200-Day MA
14.23CNYUpdated Sep 20, 2026Avg 10-Day Volume
14.37MSharesUpdated Sep 20, 2026Avg 30-Day Volume
20.64MSharesUpdated Sep 20, 2026Diluted EPS (TTM)
0.3400CNYUpdated Sep 20, 2026Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 2.56: grey zoneSignificant
Altman Z-Score: 2.56
Supply Chain
Upstream position: supplies 5 industries, depends on 1Notable
Outgoing: 5.00Incoming: 1.00
Scale
Market cap is $1.77B, above the global median of $1.18BNotable
Market cap (USD): 1,765,577,488.99Global Median: 1,180,223,658.953
Revenue is $796.68M, above the global median of $548.88MNotable
Revenue (USD): 796,682,189.722Global Median: 548,883,780.48
Levered free cash flow is $53.23M, above the global median of $18.73MNotable
Levered free cash flow (USD): 53,234,027.286Global Median: 18,729,043.027
Companies that share the same coordination system — how they create, deliver, or capture value.
Rengo Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Jiangsu Ruitai New Energy Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleFlow
Rongfa Nuclear Equipment Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
Electrolux AB
Tier 1ProductionThroughput-Bound ConversionFlowRule
Dongguan Tarry Electronics Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleFlow
Wuxi Chipown Micro-Electronics Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
Osaka Soda Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Ennoconn Corporation
Tier 1ProductionThroughput-Bound ConversionFlowRule
Dian Diagnostics Group Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleFlow
Personalis Inc.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking